Schouten, P., Gluz, O., Harbeck, N., Mohrmann, S., Diallo‐Danebrock, R., Pelz, E., . . . Marmé, F. (2016). BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial. International journal of cancer, 139(4), . https://doi.org/10.1002/ijc.30078
Chicago-Zitierstil (17. Ausg.)Schouten, Philip, et al. "BRCA1-like Profile Predicts Benefit of Tandem High Dose Epirubicin-cyclophospamide-thiotepa in High Risk Breast Cancer Patients Randomized in the WSG-AM01 Trial." International Journal of Cancer 139, no. 4 (2016). https://doi.org/10.1002/ijc.30078.
MLA-Zitierstil (9. Ausg.)Schouten, Philip, et al. "BRCA1-like Profile Predicts Benefit of Tandem High Dose Epirubicin-cyclophospamide-thiotepa in High Risk Breast Cancer Patients Randomized in the WSG-AM01 Trial." International Journal of Cancer, vol. 139, no. 4, 2016, https://doi.org/10.1002/ijc.30078.